Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics…
CoC Vault Goes Live Ahead of South Africa’s 20 September Trade Deadline
Boba Provides Corporate Update and Arranges Second $250,000 Private Placement
Cathedra Bitcoin Inc. Provides Additional Disclosure Regarding the Series I Preferred Shares Issuable in Connection with Its Plan of Arrangement with Sphere 3D Corp.
eResearch Updates Research Coverage on Turnium Technology Group